Colchicine (Lodoco) Approved to Help Prevent Heart Disease [Video]

Colchicine is an older drug that has traditionally been prescribed for gout and other inflammatory conditions. The Food and Drug Administration (FDA) approved colchicine for heart disease prevention in June of 2023.

Sold under the brand name Lodoco, colchicine can now be used in addition to cholesterol and blood pressure medications to reduce the risk of heart disease and stroke. The drug is for patients who have established coronary artery disease and those who have had a heart attack or stroke and are at risk for a recurrence.

Patients with heart disease should talk to their cardiologist about inflammation and whether colchicine is right for them. To learn more: https://www.UHhospitals.org/heart

University Hospitals is one of the nation’s leading health care systems, providing patient-centered care that meets the highest standards for quality and patient safety and have received numerous awards and recognitions from some of the most prestigious institutions in the country for our leadership and exceptional patient outcomes. As an accountable care organization, we foster long-term patient-provider relationships that help promote preventive care, increase wellness and healthy behaviors, decrease emergency episodes, and prevent hospitalizations. To learn more: https://www.uhhospitals.org